Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II CCOP Trial of High Dose Methotrexate/ARA-C and HCVAD for Newly Diagnosed Nodular and Diffuse Mantle Cell Lymphoma and Their Blastic Variants
NCT00003311Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 1998
- Primary completion
- Apr 2007
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, cytarabine, cyclophosphamide, doxorubicin, vincristine in mantle cell lymphoma (MCL), sponsored by University of Texas MD Anderson Cancer Center. Started May 1998; status: completed.
02
Drugs
methotrexatecytarabinecyclophosphamidedoxorubicinvincristine
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00003311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003311.